Dr. Mark R. Young, MD
- Medicare services, 2024
- 3,474
- Medicare patients, 2024
- 860
- Part D claims, 2024
- 2,856
- MIPS score, 2024
- 92
- Industry payments
- $3,086
- Practice address
- 755 Fallbrook Blvd, Lincoln, NE 68521
- Practice phone
- Call (402) 493-3712
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Omaha Eye & Laser Institute
Lincoln, Nebraska
Find Dr. Young's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark R. Young is an ophthalmologist in Lincoln, Nebraska
Dr. Young practices at Omaha Eye & Laser Institute in Lincoln, Nebraska.
Dr. Young's NPI, 1093790834, was assigned on December 14, 2005. Dr. Young graduated from University of Nebraska College of Medicine in 1991. Dr. Young holds Nebraska license 21253.
- NPI
- 1093790834NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5890838221
- NPI enumeration date
- December 14, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (402) 493-3712
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 61
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mark R. Young practices at Omaha Eye & Laser Institute in Lincoln, Nebraska
Dr. Young's primary practice is Omaha Eye & Laser Institute, at 755 Fallbrook Blvd, Lincoln, NE 68521 in Lancaster County. The practice phone is (402) 493-3712.
- Omaha Eye & Laser Institute755 Fallbrook Blvd, Lincoln, NE 68521 · Lancaster CountyPhone(402) 493-3712
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mark R. Young is affiliated with 2 sites of care and 1 medical group
Dr. Young's primary practice is Omaha Eye & Laser Institute in Lincoln, Nebraska. Dmand AI also links Dr. Young to 1 group practice or clinic and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Mark R. Young's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Young practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Omaha Eye & Laser Institute | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark R. Young is one of 119 ophthalmologists in Nebraska
Ophthalmology is Dr. Young's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Young is licensed in Nebraska.
Specialties and state licenses
- Ophthalmology, NebraskaPrimary
Ophthalmologists near Dr. Young
Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark R. Young billed Medicare for 3,474 services in 2024
CMS data shows 3,474 Medicare services from Dr. Young across 10 procedure codes in 2024, for 860 Medicare patients. Medicare paid $347,691 for them.
Dr. Young's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Tests and treatments
- 2023: 2,4352024: 2,6619%
- Surgery
- 2023: 8812024: 8138%
Where Dr. Young's Medicare services took place, 2024
- In an office2,66177%
- In a facility81323%
Dr. Young compared with the Nebraska median for ophthalmologists, 2024
- Dr. Young
- Nebraska median
- Medicare services
- 3,474vs 2,14962% above
- Medicare patients
- 860vs 68226% above
- Part D claims
- 2,760vs 6674.1 times
Medians across 112 ophthalmologists in Nebraska with Dmand AI profiles that report each measure.
Dr. Young's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Young?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Young and other ophthalmologists in Nebraska.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mark R. Young treated 860 Medicare patients in 2024, average age 75
CMS counts 860 Medicare patients who saw Dr. Young in 2024. The largest group is 65 to 74, with 450 patients. 69% of them have high blood pressure, and 68% have high cholesterol. 4% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Young's median patient age at 70, with 57% women.
Dr. Young's Medicare patients by age, 2024
Dr. Young's Medicare patients by sex, 2024
- Women49558%
- Men36542%
Chronic conditions among Dr. Young's Medicare patients, 2024
- High blood pressure69%
- High cholesterol68%
- Arthritis39%
- Diabetes25%
- Chronic kidney disease21%
- Ischemic heart disease20%
- Mood disorders19%
- Depression17%
Share of Medicare patients with each condition. A patient can have several.
Dr. Young's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women57%
- Men42%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mark R. Young wrote 2,856 Medicare Part D claims in 2024
In 2024, Dr. Young wrote 2,856 Medicare Part D claims for 669 patients. 67% of them were for generic drugs. CMS names the drug for 2,760 of them, across 21 drugs with 11 or more claims each, at $172,210 in total drug cost. In 2023, CMS named 4,036 claims across 24 drugs.
Dr. Young's Part D claims by kind of drug, 2024
- Generic1,913 claims67%
- Brand-name943 claims33%
Dr. Young's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4,0362024: 2,76032%
Drugs named by CMS: 21 in 2024, 24 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mark R. Young scored 92 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Young for performance year 2024, reported as part of a group. Dr. Young accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 745 procedures of cataract surgery by Dr. Young, more than 98% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
Dr. Young's MIPS scores, performance year 2024
- 92of 100Final score
- 96.9of 100Quality
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Dr. Young ranks in Medicare procedure volume
- Cataract surgery
- 98th percentile745 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark R. Young received $3,086 in industry payments from 2016 to 2025
CMS Open Payments shows 63 general payments to Dr. Young from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Glaukos Corporation paid the most, $1,319.
General payments to Dr. Young by program year, 2016 to 2025
Companies that paid Dr. Young the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mark R. Young graduated from University of Nebraska College of Medicine
Dr. Young graduated from University of Nebraska College of Medicine in 1991.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Mark R. Young's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark R. Young
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark R. Young's NPI number?
Dr. Mark R. Young's NPI number is 1093790834. It was assigned on December 14, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark R. Young?
Dr. Mark R. Young is an ophthalmologist in Lincoln, Nebraska. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).
Where does Dr. Mark R. Young practice?
Dr. Young practices at 755 Fallbrook Blvd, Lincoln, NE 68521. Dr. Young's primary practice is Omaha Eye & Laser Institute in Lincoln, Nebraska. Dmand AI also links Dr. Young to 1 group practice or clinic and 1 medical group.
What is Dr. Mark R. Young's office phone number?
The practice phone on file for Dr. Young is (402) 493-3712.
What is Dr. Mark R. Young's medical license number?
Dr. Young holds Nebraska license 21253.
Does Dr. Mark R. Young accept Medicare?
Yes. CMS data shows Dr. Young billed Medicare for 3,474 services in 2024, and Dr. Young accepts Medicare assignment.
What is Dr. Mark R. Young's MIPS score?
Dr. Young's MIPS final score for performance year 2024 is 92 out of 100, reported as part of a group.
How many Medicare patients does Dr. Mark R. Young see?
CMS counts 860 Medicare patients who saw Dr. Young in 2024, with an average age of 75.
What services does Dr. Mark R. Young bill to Medicare?
In 2024, Dr. Young's most billed Medicare services were eye exam or test (92133), eye exam or test (92014) and surgery: eye (66984).
Where did Dr. Mark R. Young go to medical school?
Dr. Young graduated from University of Nebraska College of Medicine in 1991.
Show 3 more questionsShow fewer questions
What drugs does Dr. Mark R. Young prescribe most?
In 2024 Medicare Part D data, Dr. Young's most prescribed drugs by claims were Latanoprost, Prednisolone Acetate and Dorzolamide-Timolol.
Has Dr. Mark R. Young received payments from drug or device companies?
CMS Open Payments shows $3,086 in general payments to Dr. Young from 14 companies from 2016 to 2025. The largest total came from Glaukos Corporation.
How long has Dr. Mark R. Young been practicing?
Dr. Young graduated from medical school in 1991, 35 years ago.
Selling to ophthalmology practices?
See ophthalmologists in Nebraska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card